GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » IGC Pharma Inc (FRA:IGS1) » Definitions » E10

IGC Pharma (FRA:IGS1) E10 : €-0.21 (As of Dec. 2024)


View and export this data going back to 2010. Start your Free Trial

What is IGC Pharma E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

IGC Pharma's adjusted earnings per share data for the three months ended in Dec. 2024 was €-0.019. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.21 for the trailing ten years ended in Dec. 2024.

During the past 3 years, the average E10 Growth Rate was 22.30% per year. During the past 5 years, the average E10 Growth Rate was 43.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of IGC Pharma was 56.50% per year. The lowest was 4.50% per year. And the median was 34.30% per year.

As of today (2025-03-25), IGC Pharma's current stock price is €0.284. IGC Pharma's E10 for the quarter that ended in Dec. 2024 was €-0.21. IGC Pharma's Shiller PE Ratio of today is .


IGC Pharma E10 Historical Data

The historical data trend for IGC Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

IGC Pharma E10 Chart

IGC Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.99 -0.38 -0.24 -0.21 -0.21

IGC Pharma Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.22 -0.21 -0.20 -0.19 -0.21

Competitive Comparison of IGC Pharma's E10

For the Biotechnology subindustry, IGC Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IGC Pharma's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, IGC Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where IGC Pharma's Shiller PE Ratio falls into.



IGC Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IGC Pharma's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.019/133.1571*133.1571
=-0.019

Current CPI (Dec. 2024) = 133.1571.

IGC Pharma Quarterly Data

per share eps CPI Adj_EPS
201503 -0.083 99.621 -0.111
201506 -0.027 100.684 -0.036
201509 -0.036 100.392 -0.048
201512 -0.018 99.792 -0.024
201603 -0.072 100.470 -0.095
201606 -0.018 101.688 -0.024
201609 -0.018 101.861 -0.024
201612 -0.004 101.863 -0.005
201703 -0.028 102.862 -0.036
201706 -0.018 103.349 -0.023
201709 -0.008 104.136 -0.010
201712 -0.017 104.011 -0.022
201803 -0.016 105.290 -0.020
201806 -0.017 106.317 -0.021
201809 -0.026 106.507 -0.033
201812 -0.026 105.998 -0.033
201903 -0.053 107.251 -0.066
201906 -0.027 108.070 -0.033
201909 -0.027 108.329 -0.033
201912 -0.036 108.420 -0.044
202003 -0.072 108.902 -0.088
202006 -0.044 108.767 -0.054
202009 -0.034 109.815 -0.041
202012 -0.049 109.897 -0.059
202103 -0.059 111.754 -0.070
202106 -0.033 114.631 -0.038
202109 -0.077 115.734 -0.089
202112 -0.044 117.630 -0.050
202203 -0.109 121.301 -0.120
202206 -0.047 125.017 -0.050
202209 -0.051 125.227 -0.054
202212 -0.038 125.222 -0.040
202303 -0.075 127.348 -0.078
202306 -0.037 128.729 -0.038
202309 -0.047 129.860 -0.048
202312 -0.083 129.419 -0.085
202403 -0.037 131.776 -0.037
202406 -0.028 132.554 -0.028
202409 -0.018 133.029 -0.018
202412 -0.019 133.157 -0.019

Add all the adjusted EPS together and divide 10 will get our e10.


IGC Pharma  (FRA:IGS1) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


IGC Pharma E10 Related Terms

Thank you for viewing the detailed overview of IGC Pharma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


IGC Pharma Business Description

Traded in Other Exchanges
Address
10224 Falls Road, Potomac, MD, USA, 20854
IGC Pharma Inc develops advanced cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome and chronic pain. The company has two investigational drug assets targeting Alzheimer's disease, IGC-AD1 and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles. IGC-AD1 is a low-dose tetrahydrocannabinol-based formulation that is in a 146-person Phase 2 clinical trial for agitation in dementia due to Alzheimer's. IGC also markets a wellness brand, Holief, that targets women experiencing premenstrual syndrome and menstrual cramps.

IGC Pharma Headlines

No Headlines